Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19Article Published on 2022-04-012023-07-07 Journal: The American journal of the medical sciences [Category] COVID19(2023년), [키워드] Epidemiology fatigue Infectious diseases SARS [DOI] 10.1016/j.amjms.2022.01.002 PMC 바로가기
Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age18~70세 심장 이식 환자의 SARS-CoV-2 아데노바이러스 벡터 백신 접종(ChAdOx1 nCoV-19[AZD1222])에 대한 체액 반응Article Published on 2022-04-012022-09-11 Journal: The Journal of heart and lung transplantation : th [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 95% CI Adenovirus adenovirus vector vaccine adenovirus vector vaccines administration adverse event age antibody Antibody Response binding domain ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine chronic Chronic kidney disease CKD Concentration detectable develop domain dose enrolled fatigue female headache heart heart transplant help Humoral response immune response immunogenicity Immunosuppressed immunosuppressed patients injection site pain Kidney disease less Messenger RNA minor symptom minor symptoms mycophenolate nCoV organ Patient paucity of data PCR testing predict Prospective Study receive recent recipient recipients responses SARS-CoV-2 SARS-COV-2 infection serum analysis solid organ solid organ transplant SOT Spike protein suggested the spike protein to define vaccination Vaccine vaccine doses were recorded [DOI] 10.1016/j.healun.2022.01.005 PMC 바로가기 [Article Type] Article
Pandemic fatigue, psychopathological risk factors, and vaccination attitudes during the COVID-19 pandemic in 2021–a network analysisResearch article Published on 2022-04-012022-10-05 Journal: Journal of Affective Disorders Reports [Category] 변종, [키워드] COVID-19 pandemic fatigue network analysis Risk factors vaccination [DOI] 10.1016/j.jadr.2022.100345 [Article Type] Research article
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study혈액종양 환자 및 의료 종사자에 대한 SARS-CoV-2 백신 3차 접종: 면역 반응 및 부작용 - 후향적 코호트 연구Article Published on 2022-04-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), SARS, 변종, [키워드] Adverse adverse event adverse events Analysis anti-S anti-SARS-CoV-2 antibody antibody levels B cell Cancer Care CD19 CD19+ CD56 CD56+ Cell chills Community community hospital Control correlated COVID-19 decrease dose event fatigue follow-up study haematological malignancies haematological malignancy HCW Health Health care Health care worker hospital immune response increasingly Italy local pain longitudinal longitudinal analysis Lower malignancy NK cell oncology other treatment other treatments Patient Patients with cancer patients with haematological Peripheral blood Questionnaires receiving retrieved retrospective cohort study SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 vaccination second vaccination Side-effect solid tumour Spike protein therapy trials Tumours vaccination virus variant waning immunity [DOI] 10.1016/j.ejca.2022.01.019 PMC 바로가기 [Article Type] Article
One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndromeObservational Study Published on 2022-04-012022-10-04 Journal: Infection [Category] 임상, [키워드] age blood tests change changes in clinically Complete cough COVID-19 died diffusing discharge DLCO Dyspnea ECG eligible patient evaluate Evolution fatigue Follow-up greater Hospitalization IMPROVE long-COVID lung capacity males Myocardial infarction non-ICU one patient Patient patients physical exam Post-acute sequelae of SARS-CoV-2 infection predicted Prevalence prospective observational study questionnaire remained respiratory respiratory symptom respiratory symptoms SARS-CoV-2 significant increase significantly spirometry Symptoms syndrome unit [DOI] 10.1007/s15010-022-01755-5 PMC 바로가기 [Article Type] Observational Study
Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated이집트 환자의 코로나 후 증상 예측자: COVID-19 치료에 사용된 약물은 유죄Article Published on 2022-03-312022-09-11 Journal: PLoS ONE [Category] SARS, 치료기술, [키워드] age Antibiotics Comorbidities Corticosteroid Corticosteroids COVID-19 Critical cross-sectional survey described disease drug Factor fatigue females followed by form Google indicated Infection intake International knowledge Mild mild to moderate Mild to moderate COVID-19 Moderate COVID-19 MOST participant Patient physical predictor presence of comorbidities Prevalence psychological symptom regression analysis severe Sex significantly Symptom Symptoms syndrome the disease these symptoms took place Treatment use of antibiotics was used [DOI] 10.1371/journal.pone.0266175 PMC 바로가기 [Article Type] Article
One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis낭포성 섬유증 환자의 독일 집단에서 SARS-CoV-2 유병률의 1년 모니터링Article Published on 2022-03-242022-09-12 Journal: BMC Pulmonary Medicine [Category] MERS, SARS, 진단, [키워드] anti-SARS-CoV-2 IgG antibody anticipated Clinical course Clinical data clinical impact Clinical outcome cohort of patient collected coronavirus disease cough COVID-19 described fatigue fibrosis Germany headache higher risk Hospitalized impair individual infected patient Infection Lung function molecular Nasopharyngeal swab observation pandemic Patient positive Prevalence recorded Registered Saliva SARS-CoV-2 SARS-COV-2 infection screened serology severe COVID-19 Symptom tested the SARS-CoV-2 [DOI] 10.1186/s12890-022-01900-8 PMC 바로가기 [Article Type] Article
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study Research Published on 2022-03-222022-10-05 Journal: Scientific Reports [Category] SARS, 치료법, 치료제, [키워드] Analysis Anosmia Campania Case fatality rate collected common Comorbidities comparable cough COVID-19 death diagnosis of COVID-19 died enrolled evaluate fatigue Fever Follow-up General population Hospitalization Immunosuppression incidence intensive care unit Italian liver liver transplant male median age Mortality multivariable logistic regression outcome outpatients Patient patients patients with COVID-19 recipient required respiratory risk factor Symptom symptomatic Univariate analysis [DOI] 10.1038/s41598-022-08947-x [Article Type] Research
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)코로나19 이후 증후군 및 만성 피로 증후군(ME/CFS) 환자의 내피 기능 장애 및 변경된 내피 바이오마커Article Published on 2022-03-222022-09-11 Journal: Journal of Translational Medicine [Category] MERS, SARS, 바이오마커, [키워드] ACE ACE2 age analysed angiopoietin angiotensin Angiotensin-converting enzyme association Biomarker Biomarkers blood pressure BMI chronic fatigue syndrome clinical parameter Clinical parameters cohort of patient Concentration criteria defined Diagnostic Criteria dysfunction elevated Encephalomyelitis endocan endothelial endothelial cells Endothelial dysfunction endothelial function Endotheliitis Endothelin Endothelin-1 Endothelium ET-1 Evidence exhibited fatigue fatigue syndrome FIVE HCs healthy control hyperaemia IL-8 infect investigated malaise Myalgic encephalomyelitis/chronic fatigue syndrome paradoxical Pathomechanism Patient patients peripheral positive correlation post-COVID syndrome profile reactive Reactive hyperaemia index. SARS-CoV-2 seronegative serum Sex shown significantly subgroups subset Symptom syndrome [DOI] 10.1186/s12967-022-03346-2 PMC 바로가기 [Article Type] Article
A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report건강한 일본 성인을 대상으로 한 코로나19 백신 mRNA-1273의 1/2상 무작위 위약 대조 연구: 중간 보고서Clinical Trial Published on 2022-03-182022-09-12 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome Administered adverse event AEs age AMED anti-SARS-CoV-2 immune response antibody ARMS baseline company conducted coronavirus COVID-19 COVID-19 vaccine mRNA-1273 demonstrated development dose ENCODE enrolled fatigue geometric healthy immune response immunogenicity Injection-site pain Interim report Intramuscular injection Japan Japanese Limited mRNA vaccine mRNA-1273 myalgia NAb neutralising antibody occurred outcome participant Participants pharmaceutical Placebo placebo-controlled study placebo-controlled trial randomised receive reported Safety safety profile SARS-CoV-2 SARS-COV-2 infection secondary outcome Spike protein stratified Takeda vaccination Vaccine [DOI] 10.1016/j.vaccine.2022.02.030 PMC 바로가기 [Article Type] Clinical Trial